During the past decade, University at Buffalo/Kaleida Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University at Buffalo/Kaleida Health" are "Aortic Stenosis, Severe" (1 trials), "Coronary Artery Disease" (1 trials), "Heart Diseases" (1 trials) and "Left Ventricular Dysfunction" (1 trials). Many other conditions were trialed in "University at Buffalo/Kaleida Health" in a lesser frequency.

Most popular intervention types in "University at Buffalo/Kaleida Health" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Edwards SAPIEN 3 / SAPIEN 3 Ultra THV" (1 trials), "IABP Intra-aortic balloon pump" (1 trials) and "Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®" (1 trials). Other intervention names were less common.

The vast majority of trials in "University at Buffalo/Kaleida Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University at Buffalo/Kaleida Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University at Buffalo/Kaleida Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University at Buffalo/Kaleida Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".